A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With Or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma Monika Chaudhry | January 30, 2022
A Phase I/II, First-in-Human, Open-Label, Dose Escalation Study of ZL-1211 in Patients with Unresectable or Metastatic Solid Tumor Monika Chaudhry | January 30, 2022
